Contraceptive technology:
Gespeichert in:
| Weitere Verfasser: | , , , , , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Burlington, MA
Jones & Bartlett Learning
[2025]
|
| Ausgabe: | 22nd edition |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | xlii, 777, A-5, I-26 Seiten Illustrationen, Diagramme |
| ISBN: | 9781284255034 9781284299267 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049532588 | ||
| 003 | DE-604 | ||
| 005 | 20240614 | ||
| 007 | t | ||
| 008 | 240205s2025 a||| b||| 00||| eng d | ||
| 020 | |a 9781284255034 |9 978-1-284-25503-4 | ||
| 020 | |a 9781284299267 |9 978-1-284-29926-7 | ||
| 035 | |a (OCoLC)1429572199 | ||
| 035 | |a (DE-599)BVBBV049532588 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-578 |a DE-384 | ||
| 084 | |a YM 2500 |0 (DE-625)153826:12905 |2 rvk | ||
| 084 | |a WP 630 |2 nlm | ||
| 245 | 1 | 0 | |a Contraceptive technology |c Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher |
| 250 | |a 22nd edition | ||
| 264 | 1 | |a Burlington, MA |b Jones & Bartlett Learning |c [2025] | |
| 264 | 4 | |c © 2025 | |
| 300 | |a xlii, 777, A-5, I-26 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Familienplanung |0 (DE-588)4113510-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Reproduktive Gesundheit |0 (DE-588)7726278-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Empfängnisverhütung |0 (DE-588)4070794-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Familienplanung |0 (DE-588)4113510-6 |D s |
| 689 | 0 | 1 | |a Reproduktive Gesundheit |0 (DE-588)7726278-5 |D s |
| 689 | 0 | 2 | |a Empfängnisverhütung |0 (DE-588)4070794-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Cason, Patty |4 edt | |
| 700 | 1 | |a Cwiak, Carrie |4 edt | |
| 700 | 1 | |a Edelman, Alison |4 edt | |
| 700 | 1 | |a Kowal, Deborah |4 edt | |
| 700 | 1 | |a Marrazzo, Jeanne M. |0 (DE-588)1046881671 |4 edt | |
| 700 | 1 | |a Nelson, Anita L. |0 (DE-588)138130574 |4 edt | |
| 700 | 1 | |a Policar, Michael S. |4 edt | |
| 700 | 1 | |a Hatcher, Robert A. |d 1937- |e Begründer eines Werks |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-284-25506-5 |
| 856 | 4 | 2 | |m Digitalisierung UB Augsburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Augsburg - ADAM Catalogue Enrichment |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
Datensatz im Suchindex
| _version_ | 1805081906621972480 |
|---|---|
| adam_text |
■ Contents Preface. xxx Contributors. xxxiii [ЭДМ f RTEuts «-J^^ ^^^^ , U CHAPTER 1 Reproductive 3ustice within Reproductive Healthcare.3 Talita Oseguera, CNM, WHNP-BC, MSN and Zoë Julian, MD, MPH, FACOG References6 CHAPTER 2 Understanding the Physiology of the Menstrual Cycle. 7 Anita L. Nelson, MD Overview8 The HPO Axis [The Ovarian Cycle)8 Hypothalamic-Pituitary Overview. 11 Hypothalamus. 11 Ovarian Overview. 12 Atresia of Nondominant Follicles. 17 Estrogen Rise Prior to the LH Surge. 17 Preovulation/Ovulation Phase. 19 Ovulation. 20 Luteal Phase. 21 Ovarian-Endometrial Component
(The Endometrial Cycle). 22 Menstrual Phase. 22 Changes Seen in Menstruation. 24 Proliferative Phase of the Ovarian-Endometrial Compartment. 24 Secretory Phase of the Ovarian-Endometrial Compartment. 26 Summary. 28 References. 28 ©Yuri Hoyda/Shutterstock V
vi Contents CHAPTER 3 Menstrual Disorders. 3Ί Anita L. Nelson, MD and Shivika Trivedi, MD, MSc Abnormal Menstrual Bleeding: Amenorrhea Overview. 34 Primary Amenorrhea (Absence of Menarche). 35 Secondary Amenorrhea. 37 Functional Hypothalamic Amenorrhea (FHA). 39 Treatments for Secondary Amenorrhea. 40 Abnormal Menstrual Bleeding: Infrequent Menses. 42 Polycystic Ovary Syndrome (PCOS). 42 Other Causes of Unexplained Infrequent Menses. 46 Treatments for Infrequent Menses (Including PCOS). 46 Heavy or Prolonged Menstrual Bleeding. 49 Acute Excessive Uterine Bleeding. 50 Chronic Excessive Bleeding. 51 Other Abnormal Uterine Bleeding Patterns. 62 Menstruation-Related Problems. 62 Painful Menses
(Dysmenorrhea). 62 Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD). 65 Menstrual Exacerbation of Other Medical Conditions. 69 References. 70 CHAPTER 4 Person-Centered Reproductive Health Conversations and Contraceptive Counseling. 79 Patty Cason, MS, FNP-BC and Joely Pritzker, MS, FNP-C Person-Centered Care. 80 Unintended Pregnancy in The United States. 81 Reproductive Desires. 82 Complexity of Pregnancy Desires. 82 Conversations about Reproductive Desires. 84 One Key Question. 86 PATH Questions. 86 Contraceptive Counseling; Past, Present, and Future. 90 Directive Counseling. 91 Consumerist Counseling or The “Menu”
Approach. 91 Shared Decision Making. 91 Skills To Operationalize Person-Centered Reproductive and Contraceptive Care. 92 Key Person-Centered Questions. 92 Questions for Small Talk.93 Questions That Are Open-Ended. 93
vii Contents Questions for Obtaining a Nonstigmatizing, Comprehensive Sexual History. 93 Questions for Follow Up. 93 Questions for Offering Services. 94 Questions for Eliciting Contraceptive Preferences.94 Affirm-Share-Ask Cycle.96 Affirm/Acknowledge.97 Share Content or Information. 100 Reflective Listening (Rephrasing).104 Ask A Follow Up Question.105 Specific Clinical Circumstances.107 Pregnancy Options Counseling. 110 Summary. 113 References. '. 113 CHAPTER 5 Effectiveness, Safety, and Comparative Side
Effects. 125 Sarah E.K. Bradley, PhD, MHS, Chelsea B. Polis, PhD, Elizabeth A. Micks, MD, MPH, and Markus J. Steiner, PhD, MSPH Effectiveness: "How Well Will It Work?”. 129 Data Sources and Methods for Estimating Contraceptive Effectiveness. 132 Effectiveness Over Time. 145 Simultaneous Use of Methods. 146 Factors that Influence Reported Effectiveness. 146 Pitfalls and Challenges of Communicating Pregnancy Risk. 153 Safety. 154 Major Health Risks. 154 Goals For Communicating About Safety. 156 Comparative Side Effects.160 Goals For Communicating About Side Effects. 162 References.163 CHAPTER 6 Sexuality and Contraception. 173 Jenny A. Higgins, PhD, MPH, Patty Cason, MS, FNP-PC, and Jessica N. Sanders, PhD, MSPH Gender and Sexual Identities .
. 174 Sex Brings Both Benefits and Harms. 175 The Importance of The Sexual Acceptability ofContraception. 176 Method-Specific Research on Sexual Acceptability. 179 Hormonal Methods. 179 Nonhormonal Methods. 185 Fertility Awareness-Based Methods.190
viii Contents Tools and Resources for Providing Person-Centered Care in Conversations about Patients’ Sexuality and Sexual Acceptability of Contraception. 191 Conversing With Patients About Sexuality and Contraception. 191 Offer Education about Sexual Anatomy. 194 When Is It a Sexual Dysfunction?. 194 Resources. 197 For Providers Offering Referrals for People with Sexual Concerns. 197 For Both Nonproviders and Providers Interested in Learning More about Sexuality, Pleasure, Sexual Health, and Contraception.197 References. 197 CHAPTER 7 Abstinence and Sexual Health: What Every Clinician Needs to Know. 207 John Santelli, MD, MPH, Samuel Master, DO, and Melissa Kottke, MD, MPH, MBA Definitions of Abstinence'. 208 Sexual Rights and Sexual Expression. 208 Demographics of Abstinence, Sexual Behaviors, and Marriage. . . . 209 Effectiveness. 214 Sexual
Assault. 215 Clinical Assessment and Counseling Regarding Abstinence. 216 Clinician Roles in Supporting Comprehensive Sexuality Education Programs. 217 User Instructions for Abstinence—for Contraception or STI Protection.218 References. 219 CHAPTER 8 Permanent Contraception. 223 Jewel A. Brown, MD and Melody Y. Hou, MD, MPH Mechanism of Action. 224 Advantages. 224 Disadvantages. 225 Fallopian Tube Surgery. 226 Effectiveness. 228 Intrauterine Pregnancy. 229 Ectopic Pregnancy. 229 Safety. 230 Special
Issues. 230
Contents ix Providing Tubal Surgery: Approaches and Techniques. 235 Timing. 235 Options for Approach. 236 Vas Surgery. 241 Effectiveness. 241 Safety. 242 Special Issues. 242 Vas Surgery: Approaches and Techniques. 244 Options for Approach. 244 Providing Permanent Contraception . 247 Counseling. 247 Preoperative Screening. 250 Anesthesia, Pain Management, and Antibiotics.250 Managing Problems and Follow-Up. 251 User Instructions. 251 Preoperative Instructions for
Surgery. 251 Postoperative Instructions. 252 Methods in Development. 253 References. 254 CHAPTER 9 Contraceptive Implant. 265 Melissa J. Chen, MD, MPH and Melissa C. Matulich, MD, MAS Mechanisms of Action. 266 Effectiveness. 266 Duration of Use. 266 Advantages. 267 Safety. 267 Highly Effective.267 Convenience. 267 Discreet. 268 High Rates of Continuation. 268 Menstrual-Related
Benefits. 268 Rapid Return of Fecundity. Does Not Require Examinations or Tests Prior to Initiation.268 Ease of Integrating Implant Services into Various Health Care Settings. 269 Disadvantages and Cautions. 269 Procedure-Related Risks. 269 Nonpalpable Implants. 269 Unpredictable Bleeding. 270 Other Potential Hormone-Related Side Effects. 270 Pregnancy Issues.271 268
X Contents Special Issues or Populations. 271 Efficacy in Users with Body Mass Index (BMI) S 30 kg/m2. 271 Drugs that Impact Efficacy. 272 Providing the Method. 275 Requirements for Implant Providers.275 Counseling and Informed Consent.276 Timing of Initiation. 276 Implant Placement Principles. 276 Managing Problems and Follow-Up. 284 Managing Unfavorable Bleeding. 284 Pregnancy.285 Other Problems.287 User Instructions. 287 Methods in Development. 288 References. 289 CHAPTER ΊΟ Intrauterine Devices (IUDs). 297 Nicole Economou, MD, MPH,
Biftu Mengesha, MD, MAS, and Eleanor Bimla Schwarz, MD, MS IUD Options in the United States. 298 Copper 380 mm2 (Paragard) IUD.301 Levonorgestrel IUDs.301 Mechanism of Action. 302 Effectiveness. 303 Cost-Effectiveness. 303 Advantages. 303 User Satisfaction and Continuation Rates. 304 Ectopic Pregnancy Prevention. 304 Protection from Pelvic Inflammatory Disease (PID). 304 Cancer Protection. 304 Emergency Contraception. 305 Noncontraceptive Benefits of LNG IUDs. 305 Disadvantages and Cautions. 305 Changes in Menstrual
Patterns. 306 Cramping and Pain.306 IUD Expulsion. 307 Concern of Weight Gain. 307 Pelvic Infection. 308 Perforation. 308 Pregnancy Complications.309 Providing the IUD.309 Choosing IUD Type. 309 Contraindications to IUD Use. 309
Contents Special Issues. 310 Counseling About IUDs.312 Clinician Training. 313 Timing of IUD Placement. 314 Placement Technique. 315 IUD Removal. 316 Timing of IUD Removal for Perimenopausal Patients. 316 Managing Problemsand Follow-Up. 316 Intermenstrual Bleeding, Spotting, or Excessive Menstrual Flow. 317 Chlamydia or Gonorrhea Infection Among IUD Users. 317 Pelvic Inflammatory Disease (PID). 317 Abnormal Cervical Cytology. 318 Actinomyces-like Organisms Seen on Cytology. 318 Thread Problems. 318
Expulsion. 319 Malpositioned IUDs. 319 Fractured IUDs. 319 Translocation. 320 Pregnancy with an IUD in Place. 320 User Instructions For Intrauterine Contraception. 321 For Patients Receiving a Copper IUD (Paragard). 321 For Patients Receiving an LNG IUD. 322 References. 322 CHAPTER П Injectable Contraceptives. 335 Megan Lawley, MD, MPH and Carrie Cwiak MD, MPH Mechanism of Action. 336 Effectiveness. 336 Decreasing Barriers to Care. 337 Health Disparities. 338 Access During
Pandemics. 338 Advantages. 338 Menstrual Suppression. 339 Decreased Uterine Leiomyoma Risk. 339 Treatment for Abnormal Uterine Bleeding. 339 Decreased Cancer Risk. 340 Disadvantages. 340 Unpredictable Bleeding. 340 Weight Gain. 340 Delayed Return to Fecundity. 341 Health Risks. 341 Metabolic Changes. 343 Cardiovascular Events.344 xi
xii Contents Decreased Bone Mineral Density. 344 Human Immunodeficiency Virus (HIV) Acquisition. 345 Breast Cancer. 346 Populations of Interest. 346 Breast/Chestfeeding. 346 Perimenopause. Sickle Cell Disease. 347 Providing the Method. 347 Counseling and Assessment for DMPA. 347 Choosing a Formulation. 348 When to Start DMPA.349 Switching from Other Methods. 349 Strategies to Increase Patient Satisfaction. 350 User Instructions . 350 Providing Adequate
Supplies. 351 Follow-Up. 351 Managing Issues with DMPA Use. 351 Managing Missed Injections. 351 Managing Bleeding Changes and Side Effects.352 Bleeding Changes. 352 Weight Gain and Other Side Effects. 353 When to Stop DMPA. 353 References. 354 CHAPTER 12 Combined Hormonal Contraceptives (CHCs). 359 Shaalini Ramanadhan, MD, MCR and Alison Edelman, MD, MPH Clinical Impact of Combined Hormone Contraceptives. 360 Mechanism of Action and Formulations. . 361 CHC Hormonal Components. 361 Combined Oral Contraceptives (COCs).362 Contraceptive Patches. 364
Vaginal Rings.364 Effectiveness.365 COCs. 365 Contraceptive Patches. 366 Vaginal Rings. 367 Effectiveness in Patients with Higher Body Weight. 368 Medication Interactions and the Impact on CHC Effectiveness. 369 Advantages.370 CHCs/COCs. 370 Contraceptive Patches. 374 Vaginal Rings. 375 347
Contents xiii Disadvantages and Cautions. 377 Contraceptive Disadvantages. 377 Providing the Method. 382 Medical Eligibility. 382 Chronic Medical Conditions. 382 Special Considerations for Different Life Stages.388 How to Prescribe CHCs. 390 When to Start CHCs. 391 Switching from Other Methods. 392 Choosing a Formulation. 392 User Instructions For CHCs. 393 User Instructions For COCs. 393 User Instructions For Contraceptive Patches. 393 User Instructions For Vaginal Rings. 395 NuvaRing. 395
Annovera. 396 Providing Adequate Supplies.397 Follow-Up. 397 Managing Problems Associated with use of Combined Hormonal Contraceptives. 397 Combined Oral Contraceptives. 398 Contraceptive Patches. 398 Vaginal Rings. 400 Managing Side Effects. 401 References. 405 CHAPTER 13 Progestin-only Pills.419 Charita L. Roque, MD, MPH and Anne E. Burke, MD, MPH Mechanism of Action. 419 Effectiveness. 420 Advantages. 421 Disadvantages and
Cautions. 422 Special Issues. 423 Providing the Method. 424 Managing Problems and Follow-Up. 426 User Instructions For Progestin-Only Pills. 426 Methods in Development. 428 References. 428
χΐν Contents CHAPTER 14 External (Male) Condoms. 433 Lee Warner, PhD, MPH, Markus J. Steiner, PhD, MSPH and Riley J. Steiner, PhD, MPH Mechanism of Action. 434 Condom Options.434 Condom Testing. 435 Effectiveness Against Pregnancy. 436 Advantages. 437 Disadvantages and Cautions. 438 Special Issues. 438 Providing Condoms. 440 Counseling.440 Managing Problems and Follow-Up. 442 User Instructions For Condoms. 442 References. 444 CHAPTER 15 Fertility Awareness-Based Methods. 451 Rachel Peragallo Urrutia, MD and Chelsea B. Polis, PhD Mechanism of
Action. 452 Methods Based on Tracking Days of the Menstrual Cycle. 453 Methods Based on Observation of Cervical Secretions. 453 Methods Based Primarily on Tracking Changes in Basal Body Temperature. . .453 Methods Based on Tracking Multiple Indicators of Fertility. 454 Methods Based on Urinary Hormone Monitoring. 454 FABM Apps and Devices. 454 Effectiveness. 455 Methods Based on Tracking Days of the Menstrual Cycle.457 Methods Based on Observation of Cervical Secretions. 457 Methods Based Primarily on Tracking Changes in Basal Body Temperature. . .458 Methods Based on Tracking Multiple Indicators of Fertility. 458 Methods Based on Urinary Hormone Monitoring. 458 Advantages. 458 Disadvantages and Cautions. 460 Special Issues and Populations. 460 Providing Fertility Awareness-Based Methods. 462
Counseling. 462 Provider Training. 463 Starting the Method. 464 Managing Problems and Follow-Up. 465 User Information. 466 Methods Based on Tracking Days of the Menstrual Cycle. 466 Methods Based on Observation of Cervical Secretions. 467
Contents XV Methods Based Primarily on Tracking Changes in Basal Body Temperature. 469 Methods Based on Tracking Multiple Indicators of Fertility. 470 Methods Based on Urinary Hormone Monitoring. 470 References. 472 CHAPTER 16 On-Demand, Internal Methods.477 Kelly СиIwell, MD, MPH and Joely Pritzker, MS, FNP-C Mechanism of Action. 478 Advantages. 481 For Internal, On-Demand Contraceptives as a Group. 481 Disadvantages. 481 For Internal, On-Demand Contraceptives as a Group. 481 Internal Condom (FC2) . 482 Effectiveness. 482 Advantages. 482 Disadvantages. 483 User Instructions For FC2.
484 Caya Diaphragm. 486 Effectiveness. 486 Advantages.488 Disadvantages. 488 User Instructions For Caya Diaphragm. 490 FemCap Cervical Cap. 490 Effectiveness. 490 Advantages. 491 Disadvantages. 492 User Instructions For Femcap. 492 Spermicides. 493 Mechanisms of Action.494 Effectiveness. 494
Advantages. 495 Disadvantages. 496 User Instructions For Spermicides. 496 Vaginal pH Modulator. 496 Effectiveness. 497 Mechanism of Action.497 Advantages. 498 Disadvantages. 498 User Instructions For PHEXXI. 499 References. 499
xvi Contents CHAPTER 17 Coitus Interruptus (Withdrawal, the Pull-Out Method). 503 Rachel K. Jones, PhD Mechanism of Action.504 Effectiveness. 504 Advantages. 505 Disadvantages and Cautions. 505 Special Issues. 505 Sexually Transmitted Infections. . 505 Use Patterns.506 Providing the Method. 507 User Instructions For Coitus Interruptus. 508 References. 508 CHAPTER 18 Emergency Contraception. 511 Eleanor Bimla Schwarz, MD, MS, Kelly Cleland, MPA, MPH and David Turok, MD, MPH Overview. 511 Barriers to Use. 512 Promoting Awareness and Use. 514 Over-the-
Counter (OTC) Availability. 515 Cost-Effectiveness. 515 Mechanism of Action. 516 Copper IUDs. 516 Levonorgestrel 52 mg IUDs. 516 Emergency Contraceptive Pills (ECPs). 516 Effectiveness. 519 Intrauterine Devices. 519 ECPs. 519 Repeated Use. 522 Population Impact of ECPs. 522 Reproductive Coercion and Emergency Contraception. 522 Advantages and Indications. 523 Side Effects. 524
Cautions. 525 Providing Emergency Contraception. 527 Counseling. 527 Before Providing Emergency Contraceptive Treatment. 530 After Providing EC Treatment. 531 Advance Prescription of UPA. 531 Additional Information and Materials. 531
Contents xvii User Instructions For Emergency Contraception. 531 References 532 CHAPTER 19 Contraception After Pregnancy. 545 Crystal Goldsmith, MD, MS and Melissa Kottke, MD, MPH, MBA Counseling about Contraception After Pregnancy. 546 Postpartum Infertility. 546 Postpartum Sexual Activity. 546 Birth Spacing Recommendations. 547 System Factors. 547 Patient Preferences and Goals. 547 Individualized Recommendations and Timing of Initiation.549 Postpartum Considerations for Contraceptive Methods. 550 Lactational Amenorrhea Method (LAM). 550 Permanent Contraception. 553 Intrauterine Devices. 554 Progestin-only Contraception.555 Combined Hormonal Contraception. 556
Other Methods. 557 Summary. 558 Resources for Patients. 558 References. 558 CHAPTER 20 Contraception for People with Medical Conditions.563 Jennifer Villavicencio, MD, MPP and Rebecca H. Allen, MD, MPH The Safety of Contraceptive Methods. 564 Understanding Risk Estimates. 564 Risks of Pregnancy. 569 CDC Medical Eligibility Criteria for Contraceptive Use. 569 Development of the Guidelines. 569 Using the Recommendations in Practice. 570 For Medical Conditions Not Listed in the US MEC. 572 Assessment of Medical Eligibility for Contraception. 572 Counseling Patients with Medical Conditions on Contraceptive Methods. . .577
References. 579
xviii Contents CHAPTER 21 Contraception in the Later Reproductive Years. 581 Amanda Y. Black, MD, MPH, Alexandra Sherman, WHNP-BC, MSCP and Taniqua A. Miller, MD, MSCP Perimenopause and Menopause. 582 What is the Probability of Pregnancy in Perimenopause?. 582 What are the Reproductive Outcomes if Pregnancy Occurs During Perimenopause?. 583 Contraception During the Later Reproductive Years. 583 Contraceptive Options During the Later Reproductive Years. 585 Contraceptive Options During Perimenopause. 585 When Can Contraception Be Reliably Stopped?. 590 Transitioning to Menopausal Hormone Therapy. 591 Summary. 592 References. 592 CHAPTER 22 Contraception for Lesbian, Cay, Bisexual, Transgender, Gender Diverse, Queer/Questioning, Intersex, and Asexual Individuals. 597 Chance Krempasky, BSN, MSN, FNP-BC, WHNP-BC, AAHIVS, Lola Pellegrino, BSN, MSN, ANP-BE, WHNP-BC, Miles S. Harris, BSN, MSN, FNP-BC, AAHIVS, and Frances Grimstad, MD, MS Language and
Terminology. 598 Gender-Affirming, Anatomy-, Identity-, and Activity-Inclusive Sexual History.602 Bodily Autonomy. 605 Contraception for TGD Individuals Assigned Female at Birth. 606 Physiology of Gender-Affirming Testosterone, Implications for Contraception, and Fertility.606 Contraceptive Counseling for TGD Individuals Assigned Female at Birth. 607 Emergency Contraception. 609 Permanent Contraception and Hysterectomy.609 Menstrual Suppression. 610 Contraception for TGD Individuals Assigned Male at Birth. 610 Contraception for Lesbian, Gay, and Bisexual Cisgender Women . 611 Fertility Counseling. 612
Summary.613 References. 613
Contents CHAPTER 23 Reproductive Tract Infections, Including HIV and Other Sexually Transmitted Infections xix 621 Jeanne Μ. Marrazzo, MD, MPH and Ina U. Park, MD, MS Magnitude and Risks of RTI .622 Transmission of RTI. 623 RTI Risk Assessment, Prevention, and Risk Behaviors. 624 Contraceptive Choice. 624 Other Behaviors Linked to RTIs. 626 Assessment, Diagnosis, and Treatment of RTI. 626 Routine Screening for RTI. 627 Counseling Patients About RTI Diagnosis and Treatment. 627 RTIs During Pregnancy. 630 RTIs and Sexual Assault. . 632 Special Considerations Regarding RTI Evaluation in the Reproductive Health Setting. 633 Other Key Points. 633 Counseling About Safer Sex. 634 Specific Concerns Related to HIV.
635 Postexposure Prophylaxis, Sex, and Drugs. 635 Factors Affecting Sexual Transmission of HIV. 635 HIV Testing and Counseling. 636 Clinical Characteristics of HIV Infection. 639 Summary of Major Reproductive Tract Infections (Other Than HIV) By Syndrome. 643 Vulvovaginal Syndromes. 643 Discrete Genital Lesions: Genital Ulcer Diseases (GUD), Including Genital Herpes and Warts. 647 Chlamydia- and Gonorrhea-Related Syndromes: Cervicitis, Urethritis, and Pelvic Inflammatory Disease. 655 Urethritis, Including Nongonococcal Urethritis (NGU). 659 Viral Hepatitis. 661 Consultation for Complex RTI Cases. 663 References. 663 CHAPTER 24 Screening for Cervical, Ovarian, and Breast Cancer. 667 Michael S. Policar, MD, MPH, George F. Sawaya, MD and Patty Cason,
MS, FNP-BC Cervical Cancer. 670 The Natural History of Cervical Cancer. 670 Risk Factors for Cervical Cancer. 671
XX Contents Primary Prevention of Cervical Cancer with HPV Vaccination. 672 Secondary Prevention of Cervical Cancer with Cervical Cancer Screening . . . 674 Management of Abnormal Screening Test Results. 679 Ovarian Cancer. 682 Ovarian Cancer Screening. 683 Breast Cancer.685 Breast Cancer Screening.688 References.692 CHAPTER 25 Pregnancy Testing.699 Maureen K. Baldwin, MD, MPH and Beatrice A. Chen, MD, MPH Pregnancy Testing Opportuntities . 699 Disclosing a Pregnancy Test Result. 700 Pregnancy Care Referral.701 Pregnancy Tests and Contraception. 702 Pregnancy Tests Prior to Contraception. 702 Positive Pregnancy Test with Contraceptive Use. 703 Pregnancy Tests for Human Chorionic Gonadotropin [hCG]. 705 Introduction to hCG
Tests. 705 Highly Sensitive Urine Pregnancy Tests. 706 Low-Sensitivity Urine Pregnancy Tests. 707 Semi-quantitative Urine Pregnancy Tests. 707 Quantitative Serum hCG Tests. 708 Pitfalls of Pregnancy Tests. 708 Serum hCG Levels in Early Pregnancy. 710 References. 713 CHAPTER 26 Abortion 719 Siripanth Nippita, MD, MS and Maureen Paul, MD, MPH Safety of Abortion. 720 Abortion and Public Health. 720 Incidence. 720 Characteristics of Individuals Who Obtain Abortions. 722 Public Health Benefits. 722 Access to Legal Abortion: Brief History. 723 Evaluation and Preparation of Patients for
Abortion. 724 Deciding Whether to Continue a Pregnancy. 724 Pre-abortion Evaluation. 725 Patient Education and Informed Consent. 730
xxi Contents Provision of Abortion Methods.732 Early Medication Abortion. 732 Uterine Aspiration Abortion. 740 Dilation and Evacuation.743 Medication Abortion Later in Pregnancy. 743 Cervical Preparation. 743 Managing Postabortion Adverse Events and Morbidity. 745 Long-Term Health Outcomes. 748 Postabortion Contraception. 749 References. 752 1 ■—1 CHAPTER 27 Digital Resources for Health and Medical Information. 767 Brian T. Nguyen, MD, MSc and Leo Han, MD, MPH The Rise of Digital Resources. 768 The Impact of Digital Resources. 769 The Perils of Digital Resources. . 769 The Range of Digital
Resources.770 Digital Resources Within Contraceptive Technology. 770 Digital Resources from Professional Groups and Societies. 771 Conclusion and Future Directions.776 References. 776 AppendixA: Summary Chart of United States Medical Eligibility Criteria for Contraceptive Use. . . A-l Appendix A is also available in color in the eBook. Appendix B: Method Efficacy Tables. . B-l Available in the eBook. Navigate eBook access is included with each new print copy of the textbook. Index .1-1
Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne Μ. Marrazzo, Anita L Melson, Michael S. Policar Founding Author; Robert A. Hatcher Contraceptiv8Technology.org Ctatraceptivt fcchnoltgr b a one-stop, person centered reference guide for students and practitioners in sexual and reproductive healthcare professions Whether it is family planning, menstrual disorders, discussing reproductive desires, maintaining contraception while managing a specific condition, abortion, reproductive tract infection, or post partum contraception, this trusted resource can be referenced in any situation when working with patients seeking guidance on reproduction, sexual health, and contraceptive options Now in its Twenty Second edition, this best selling reference provides breadth, depth of knowledge, and expansive research from over 85 medical experts in the fields of contraception, sexual health, reproductive health, and infectious disease. With a holistic approach, this edition continues the tradition ol focusing on the individual patients, meeting them where they are to offer respectful, appropriate care and services. Contraceptive Technology elevates awareness ol new and time honored technologies available in contraception, demystifies misperceptions, provides current, tact based information, and emphasizes a person centered approach. OUTSTANDING FEATURES: • Mi W chapter discusses inequities Md disparities in reproductive he Jtth • Ni W chapter offers comprehensive, detailed information on reproductive health care tor ICBIQIA* individuals. • Provides a cutting-edge
interpretation and explanation ot effectiveness and efficacy rates • Offers education tor stedewts and practicing providers и how te approach conversations with patients on controversial topics. • Guidance on best practices for challenging situations and perplexing diagnoses on a wide range of contraceptive and sexual health issues. |
| adam_txt | |
| any_adam_object | 1 |
| any_adam_object_boolean | |
| author2 | Cason, Patty Cwiak, Carrie Edelman, Alison Kowal, Deborah Marrazzo, Jeanne M. Nelson, Anita L. Policar, Michael S. |
| author2_role | edt edt edt edt edt edt edt |
| author2_variant | p c pc c c cc a e ae d k dk j m m jm jmm a l n al aln m s p ms msp |
| author_GND | (DE-588)1046881671 (DE-588)138130574 |
| author_facet | Cason, Patty Cwiak, Carrie Edelman, Alison Kowal, Deborah Marrazzo, Jeanne M. Nelson, Anita L. Policar, Michael S. |
| building | Verbundindex |
| bvnumber | BV049532588 |
| classification_rvk | YM 2500 |
| ctrlnum | (OCoLC)1429572199 (DE-599)BVBBV049532588 |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| edition | 22nd edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV049532588</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240614</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">240205s2025 a||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781284255034</subfield><subfield code="9">978-1-284-25503-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781284299267</subfield><subfield code="9">978-1-284-29926-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1429572199</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049532588</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-384</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YM 2500</subfield><subfield code="0">(DE-625)153826:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WP 630</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Contraceptive technology</subfield><subfield code="c">Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">22nd edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Burlington, MA</subfield><subfield code="b">Jones & Bartlett Learning</subfield><subfield code="c">[2025]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2025</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xlii, 777, A-5, I-26 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Familienplanung</subfield><subfield code="0">(DE-588)4113510-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Reproduktive Gesundheit</subfield><subfield code="0">(DE-588)7726278-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Empfängnisverhütung</subfield><subfield code="0">(DE-588)4070794-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Familienplanung</subfield><subfield code="0">(DE-588)4113510-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Reproduktive Gesundheit</subfield><subfield code="0">(DE-588)7726278-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Empfängnisverhütung</subfield><subfield code="0">(DE-588)4070794-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cason, Patty</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cwiak, Carrie</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Edelman, Alison</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kowal, Deborah</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marrazzo, Jeanne M.</subfield><subfield code="0">(DE-588)1046881671</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nelson, Anita L.</subfield><subfield code="0">(DE-588)138130574</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Policar, Michael S.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hatcher, Robert A.</subfield><subfield code="d">1937-</subfield><subfield code="e">Begründer eines Werks</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-284-25506-5</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Augsburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Augsburg - ADAM Catalogue Enrichment</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield></record></collection> |
| id | DE-604.BV049532588 |
| illustrated | Illustrated |
| index_date | 2024-07-03T23:27:11Z |
| indexdate | 2024-07-20T07:24:13Z |
| institution | BVB |
| isbn | 9781284255034 9781284299267 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034878197 |
| oclc_num | 1429572199 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-578 DE-384 |
| owner_facet | DE-355 DE-BY-UBR DE-578 DE-384 |
| physical | xlii, 777, A-5, I-26 Seiten Illustrationen, Diagramme |
| publishDate | 2025 |
| publishDateSearch | 2024 |
| publishDateSort | 2024 |
| publisher | Jones & Bartlett Learning |
| record_format | marc |
| spelling | Contraceptive technology Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher 22nd edition Burlington, MA Jones & Bartlett Learning [2025] © 2025 xlii, 777, A-5, I-26 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Familienplanung (DE-588)4113510-6 gnd rswk-swf Reproduktive Gesundheit (DE-588)7726278-5 gnd rswk-swf Empfängnisverhütung (DE-588)4070794-5 gnd rswk-swf Familienplanung (DE-588)4113510-6 s Reproduktive Gesundheit (DE-588)7726278-5 s Empfängnisverhütung (DE-588)4070794-5 s DE-604 Cason, Patty edt Cwiak, Carrie edt Edelman, Alison edt Kowal, Deborah edt Marrazzo, Jeanne M. (DE-588)1046881671 edt Nelson, Anita L. (DE-588)138130574 edt Policar, Michael S. edt Hatcher, Robert A. 1937- Begründer eines Werks oth Erscheint auch als Online-Ausgabe 978-1-284-25506-5 Digitalisierung UB Augsburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Augsburg - ADAM Catalogue Enrichment application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Contraceptive technology Familienplanung (DE-588)4113510-6 gnd Reproduktive Gesundheit (DE-588)7726278-5 gnd Empfängnisverhütung (DE-588)4070794-5 gnd |
| subject_GND | (DE-588)4113510-6 (DE-588)7726278-5 (DE-588)4070794-5 |
| title | Contraceptive technology |
| title_auth | Contraceptive technology |
| title_exact_search | Contraceptive technology |
| title_exact_search_txtP | Contraceptive technology |
| title_full | Contraceptive technology Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher |
| title_fullStr | Contraceptive technology Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher |
| title_full_unstemmed | Contraceptive technology Patty Cason, Carrie Cwiak, Alison Edelman, Deborah Kowal, Jeanne M. Marrazzo, Anita L. Nelson, Michael S. Policar ; founding author: Robert A. Hatcher |
| title_short | Contraceptive technology |
| title_sort | contraceptive technology |
| topic | Familienplanung (DE-588)4113510-6 gnd Reproduktive Gesundheit (DE-588)7726278-5 gnd Empfängnisverhütung (DE-588)4070794-5 gnd |
| topic_facet | Familienplanung Reproduktive Gesundheit Empfängnisverhütung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=034878197&sequence=000003&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT casonpatty contraceptivetechnology AT cwiakcarrie contraceptivetechnology AT edelmanalison contraceptivetechnology AT kowaldeborah contraceptivetechnology AT marrazzojeannem contraceptivetechnology AT nelsonanital contraceptivetechnology AT policarmichaels contraceptivetechnology AT hatcherroberta contraceptivetechnology |